These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 36987154)

  • 21. Potential in exosome-based targeted nano-drugs and delivery vehicles for posterior ocular disease treatment: from barriers to therapeutic application.
    Peng X; Zhang T; Liu R; Jin X
    Mol Cell Biochem; 2024 Jun; 479(6):1319-1333. PubMed ID: 37402019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
    Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
    Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy.
    Luo LJ; Nguyen DD; Lai JY
    Biomaterials; 2020 Jun; 243():119961. PubMed ID: 32171102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
    Wang R; Gao Y; Liu A; Zhai G
    J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects.
    Li S; Chen L; Fu Y
    J Nanobiotechnology; 2023 Jul; 21(1):232. PubMed ID: 37480102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flexible polymeric nanosized micelles for ophthalmic drug delivery: research progress in the last three years.
    Li Z; Liu M; Ke L; Wang LJ; Wu C; Li C; Li Z; Wu YL
    Nanoscale Adv; 2021 Sep; 3(18):5240-5254. PubMed ID: 36132623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives.
    Kaushal U; Kaur M; Nagpal M; Bhuyan M; Gounder KP
    Curr Drug Res Rev; 2023; 15(1):15-28. PubMed ID: 36100986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy.
    Akulo KA; Adali T; Moyo MTG; Bodamyali T
    Polymers (Basel); 2022 Jun; 14(12):. PubMed ID: 35745935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanocarriers for ocular drug delivery: current status and translational opportunity.
    Gorantla S; Rapalli VK; Waghule T; Singh PP; Dubey SK; Saha RN; Singhvi G
    RSC Adv; 2020 Jul; 10(46):27835-27855. PubMed ID: 35516960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.
    Durak S; Esmaeili Rad M; Alp Yetisgin A; Eda Sutova H; Kutlu O; Cetinel S; Zarrabi A
    Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32570885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developments in Emerging Topical Drug Delivery Systems for Ocular Disorders.
    Mandal S; Vishvakarma P; Bhumika K
    Curr Drug Res Rev; 2023 Dec; ():. PubMed ID: 38158868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.
    Cholkar K; Patel A; Vadlapudi AD; Mitra AK
    Recent Pat Nanomed; 2012; 2(2):82-95. PubMed ID: 25400717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics.
    Grimaudo MA; Pescina S; Padula C; Santi P; Concheiro A; Alvarez-Lorenzo C; Nicoli S
    Expert Opin Drug Deliv; 2019 Apr; 16(4):397-413. PubMed ID: 30889977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration.
    Gote V; Ansong M; Pal D
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):885-906. PubMed ID: 32729364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in Nanogels for Topical Drug Delivery in Ocular Diseases.
    Wu Y; Tao Q; Xie J; Lu L; Xie X; Zhang Y; Jin Y
    Gels; 2023 Apr; 9(4):. PubMed ID: 37102904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular drug delivery systems: An overview.
    Patel A; Cholkar K; Agrahari V; Mitra AK
    World J Pharmacol; 2013; 2(2):47-64. PubMed ID: 25590022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds.
    Razavi MS; Ebrahimnejad P; Fatahi Y; D'Emanuele A; Dinarvand R
    Front Chem; 2022; 10():850757. PubMed ID: 35494641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promising therapeutic drug delivery systems for glaucoma: a comprehensive review.
    Singh RB; Ichhpujani P; Thakur S; Jindal S
    Ther Adv Ophthalmol; 2020; 12():2515841420905740. PubMed ID: 32206746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.